HPV Vaccine VIS | Vaccines & Immunizations | CDC
Summary: This CDC Vaccine Information Statement (VIS) provides essential information about the HPV vaccine, including its purpose in preventing various cancers, recommended dosing schedules, potential side effects, and guidance for patients and healthcare providers.
The HPV Vaccine Information Statement (VIS), updated August 6, 2021, explains the importance of the human papillomavirus vaccine in preventing over 90% of HPV-related cancers, including cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers, as well as anogenital warts. The document outlines the recommended vaccination schedule: routine vaccination for adolescents at 11 or 12 years of age, with availability starting at age 9 and recommended through age 26. Adults aged 27–45 may receive the vaccine based on clinical discussion. It details the dosing requirements (2 doses for those starting before age 15; 3 doses for those starting at or after age 15 or with immunocompromising conditions). The VIS also covers safety, common side effects like soreness or fever, the importance of reporting adverse reactions to VAERS, and information regarding the National Vaccine Injury Compensation Program (VICP).
Document outline
1. 1. Why get vaccinated? 2. 2. HPV vaccine 3. 3. Talk with your health care provider 4. 4. Risks of a vaccine reaction 5. 5. What if there is a serious problem? 6. 6. The National Vaccine Injury Compensation Program 7. 7. How can I learn more?